Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

ClinicalTrials.gov ID: NCT05056727

Public ClinicalTrials.gov record NCT05056727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, International, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on CKD Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of Sodium Zirconium Cyclosilicate (SZC), as adjunct to ACEi/ARB therapy (lisinopril or valsartan), on slowing CKD progression (assessed as the reduction in participant's glomerular filtration rate \[eGFR\] decline over time) in participants with hyperkalaemia or at high risk of hyperkalaemia.

Study identification

NCT ID
NCT05056727
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,112 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2021 (Actual)
Primary completion
Feb 7, 2024 (Actual)
Completion
Feb 7, 2024 (Actual)
Last update posted
Jan 8, 2026

2021 – 2024

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Research Site Surprise Arizona 85374 —
Research Site Tucson Arizona 85741 —
Research Site Canyon Country California 91351 —
Research Site Chula Vista California 91910 —
Research Site Northridge California 91324 —
Research Site San Dimas California 91773 —
Research Site South Gate California 90280 —
Research Site Tarzana California 91356 —
Research Site Denver Colorado 80230 —
Research Site Boynton Beach Florida 33435 —
Research Site Hialeah Florida 33012 —
Research Site Lauderdale Lakes Florida 33313 —
Research Site Ocoee Florida 34761 —
Research Site Temple Terrace Florida 33637 —
Research Site Nampa Idaho 83687 —
Research Site Chicago Illinois 60643 —
Research Site Oak Brook Illinois 60523 —
Research Site Fort Wayne Indiana 46804 —
Research Site Louisville Kentucky 40205 —
Research Site Boston Massachusetts 02114 —
Research Site Boston Massachusetts 02115 —
Research Site Flint Michigan 48532 —
Research Site Saint Clair Shores Michigan 48081 —
Research Site Columbia Missouri 65201 —
Research Site Kansas City Missouri 64111 —
Research Site Albuquerque New Mexico 87109 —
Research Site Albany New York 12205 —
Research Site Great Neck New York 11021 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Cincinnati Ohio 45267 —
Research Site Bethlehem Pennsylvania 18017 —
Research Site Chester Pennsylvania 19013 —
Research Site Columbia South Carolina 29203 —
Research Site Orangeburg South Carolina 29118 —
Research Site Chattanooga Tennessee 37404 —
Research Site Arlington Texas 76015 —
Research Site Fort Worth Texas 76164 —
Research Site Houston Texas 77004 —
Research Site Houston Texas 77054 —
Research Site Houston Texas 77099 —
Research Site San Antonio Texas 78212 —
Research Site Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 234 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05056727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05056727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →